Kevin Blades

Title: Kevin Blades - Innovator in Phthalazinone Derivatives

Introduction

Kevin Blades is a notable inventor based in Alderley Park, GB. He has made significant contributions to the field of chemistry, particularly with his work on phthalazinone derivatives. His innovative approach has led to the development of a unique compound that holds potential applications in various industries.

Latest Patents

Kevin Blades holds a patent for phthalazinone derivatives, which is described by the formula (I). In this formula, A and B together represent an optionally substituted, fused aromatic ring. The variables X and Y can be selected from CH and CH, CF and CH, CH and CF, and N and CH, respectively. Additionally, R is selected from H or Calkyl, while R is chosen from Calkyl, Heterocyclyl, and Aryl, with the possibility of these groups being optionally substituted. Furthermore, R and R together with the carbon and oxygen atoms to which they are attached can form a spiro-Coxygen-containing heterocyclic group, which may also be optionally substituted or fused to an aromatic ring.

Career Highlights

Kevin Blades is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative research and development in the pharmaceutical sector. His expertise in chemistry and patent development has positioned him as a valuable asset to the company.

Collaborations

Kevin has collaborated with several talented individuals in his field, including Keith Allan Menear and Muhammad Hashim Javaid. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in their respective research areas.

Conclusion

Kevin Blades is a distinguished inventor whose work on phthalazinone derivatives exemplifies innovation in chemistry. His contributions to AstraZeneca and collaborations with fellow researchers highlight his commitment to advancing scientific knowledge and technology.